Oops! Something went wrong while submitting the form.
Filtered by
Tag value
Protocol
Pregnancy Exposures and Outcomes in Women with Psoriasis Treated with Risankizumab: A Cohort Study Utilizing Large Electronic Healthcare Databases with Mother-Baby Linkage in the United States
March 16, 2021
Authors:
Harvard Pilgrim Health Care Institute, Reagan-Udall Foundation for FDA, CVS Health, Carelon Research, Humana HealthCare Research, Health Partners Institute, AbbVie
Capabilities:
,
Pregnancy & Mother-Infant Linked Studies
,
Multi-Site Methods & Coordination
Expertise:
,
Regulatory Research & Support
,
RWE Research & Consulting
Publication
Utilization Patterns and Characteristics of Users of Biologic Anti-Inflammatory Agents in a Large, US Commercially Insured Population
Pharmacology Research & Perspectives
February 1, 2021
Authors:
Mendelsohn AB, Nam YH, Marshall J, McDermott CL, Kochar B, Kappelman MD, Brown JS, Lockhart CM
Expertise:
,
RWE Research & Consulting
Publication
Patient Characteristics and Utilization Patterns of Short-Acting Recombinant Granulocyte Colony-Stimulating Factor (G-CSF) Biosimilars Compared to Their Reference Product
Drugs - Real World Outcomes
January 30, 2021
Authors:
Mendelsohn AB, Marshall J, McDermott CL, Pawloski PA, Brown JS, Lockhart CM
Expertise:
,
RWE Research & Consulting
Conference Abstract
Validity of a State-Based Death Certificate/Health Plan Linkage to Support Mortality Studies
36th Annual International Society for Pharmacoepidemiology Conference
November 4, 2020
Authors:
Adgent M, Fuller C, Morrow T, Whitmore C, Grijalva C, Hua W, Dutcher S, Toh S, Griffin M
Capabilities:
,
Validation Studies & Algorithm Development
Expertise:
,
RWE Research & Consulting
,
Regulatory Research & Support
Conference Abstract
Selecting an Appropriate Comparator Group in Vaccine Cohort Studies of Older Adults: Recombinant Zoster Vaccine (RZV) as an Example
36th Annual International Society for Pharmacoepidemiology Conference
September 16, 2020
Authors:
Han J, Talarico C, Back S, dosReis S, Jamal-Allial A, McMahill-Walraven C, Menzin T, Nair V, Nam YH, Ocran-Appiah J, Brown J, Yih WK
Capabilities:
,
Multi-Site Methods & Coordination
Expertise:
,
Regulatory Research & Support
,
RWE Research & Consulting
Protocol
A Targeted Safety Study, EPI-ZOSTER-030 VS US DB, to Evaluate the Safety of Shingrix in Adults ≥ 50 Years of Age in the United States
September 11, 2020
Authors:
Harvard Pilgrim Health Care Institute, CVS Health, Carelon Research, Humana HealthCare, Optum Epidemiology, GlaxoSmithKline
Capabilities:
,
Validation Studies & Algorithm Development
,
Multi-Site Methods & Coordination
Expertise:
,
Regulatory Research & Support
,
RWE Research & Consulting
Conference Abstract
“To Link or Not to Link?” Strengths, Challenges and Applications of HCSRN Mortality Data and NDI Data Linkage
26th Annual Health Care Systems Research Network Conference
April 8, 2020
Authors:
Fuller CC, Ng D, Eworuke E, Lyons J, Shoup JA
Capabilities:
,
Multi-Site Methods & Coordination
Expertise:
,
Regulatory Research & Support
,
RWE Research & Consulting
Publication
Incidence of Serious Infections and Design of Utilization and Safety Studies for Biologic and Biosimilar Surveillance
Journal of Managed Care & Specialty Pharmacy
April 1, 2020
Authors:
Zhang J, Sridhar G, Barr CE, Eichelberger B, Lockhart CM, Marshall J, Clewell J, Accortt NA, Curtis JR, Holmes C, McMahill-Walraven CN, Brown JS, Haynes K.
Expertise:
,
RWE Research & Consulting
Conference Abstract
Use of Mepolizumab Among Individuals with Asthma in the U.S.
American Thoracic Society Conference 2020
February 1, 2020
Authors:
Wu AC, McMahon P, Mendelsohn A, Welch E, Gokhale M, McMahill-Walraven C, Zhang J, Jamal-Allial A, Gallagher M, Draper C, Kline A, Koerner L, Brown J, VanDyke M
Capabilities:
,
Multi-Site Methods & Coordination
Expertise:
,
Regulatory Research & Support
,
RWE Research & Consulting
Publication
Considerations for Using Distributed Research Networks to Conduct Aspects of Randomized Trials
Contemporary Clinical Trials Communications
January 2, 2020
Authors:
Marsolo KA, Brown JS, Hernandez AF, Hammill BG, Raman SR, Syat B, Platt R, Curtis LH
Expertise:
,
RWE Research & Consulting
Publication
Mapping from the International Classification of Diseases (ICD) 9th to 10th Revision for Research in Biologics and Biosimilars Using Administrative Healthcare Data
Pharmacoepidemiology & Drug Safety
December 18, 2019
Authors:
He M, Santiago Ortiz AJ, Marshall J, Mendelsohn AB, Curtis JR, Barr CE, Lockhart CM, Kim SC
Expertise:
,
RWE Research & Consulting
Publication
Capture of Biologic and Biosimilar Dispensings in a Consortium of U.S.-Based Claims Databases - Utilization of National Drug Codes and HCPCS Modifiers in Medical Claims
Pharmacoepidemiology & Drug Safety
December 4, 2019
Authors:
Zhang J, Haynes K, Mendelsohn AB, Marshall J, Barr CE, McDermott C, Brown J, Kline A, Kenney J, King KJ, Holmes C, Yeung K, Barron J, Yun H, Lockhart CM
Expertise:
,
RWE Research & Consulting
Publication
Descriptive Analysis of Long- and Intermediate-Acting Insulin and Key Safety Outcomes in Adults with Type 2 Diabetes Mellitus
Journal of Managed Care & Specialty Pharmacy
November 1, 2019
Authors:
Kent DJ, McMahill-Walraven CN, Panozzo CA, Pawloski PA, Haynes K, Marshall J, Brown J, Eichelberger B, Lockhart CM
Capabilities:
,
Multi-Site Methods & Coordination
Expertise:
,
RWE Research & Consulting
Publication
Harnessing the Biologics and Biosimilars Collective Intelligence Consortium to Evaluate Patterns of Care
Journal of Managed Care & Specialty Pharmacy
November 1, 2019
Authors:
McMahill-Walraven CN, Kent DJ, Panozzo CA, Pawloski PA, Haynes K, Marshall J, Brown J, Eichelberger B, Lockhart CM
Expertise:
,
RWE Research & Consulting
Protocol
Post-Authorization Safety Study to Assess the Risk of Diabetic Ketoacidosis Among Type 2 Diabetes Mellitus Patients Treated with Ertugliflozin Compared to Patients Treated with Other Antihyperglycemic Agents
October 17, 2019
Authors:
Harvard Pilgrim Health Care Institute, Reagan-Udall Foundation for FDA, CVS Health, Carelon Research, Humana HealthCare Research, Health Partners Institute, Marshfield Clinic Health System, Vanderbilt University Medical Center, Meyers Primary Care Institute, Optum Epidemiology, Merck Sharp & Dohme LLC
Capabilities:
,
Multi-Site Methods & Coordination
Expertise:
,
Regulatory Research & Support
,
RWE Research & Consulting
Publication
Antibiotic Dispensing Following Pediatric Visits in the US Emergency Departments and Outpatient Settings from 2006 to 2016
Pharmacology Research & Perspectives
October 7, 2019
Authors:
Agiro A, Sridhar G, Gordon A, Brown J, Haynes K
Capabilities:
,
Multi-Site Methods & Coordination
Expertise:
,
RWE Research & Consulting
Publication
Barriers and Facilitators to Conduct High-Quality, Large-Scale Safety and Comparative Effectiveness Research: The Biologics and Biosimilars Collective Intelligence Consortium Experience
Pharmacoepidemiology & Drug Safety
August 11, 2019
Authors:
Lockhart CM, McDermott CL, Felix T, Lin ND, Cziraky MJ, Mendelsohn AB, Brown JS
Expertise:
,
RWE Research & Consulting
Conference Abstract
ICD-9 to ICD-10 Mapping for Research in Biologics and Biosimilars Using Administrative Healthcare Data
International Society for Pharmacoeconomics and Outcomes Research Conference 2019
May 1, 2019
Authors:
He M, Ortiz AJ, Marshall J, Mendelsohn AB, Curtis JR, Barr CE, Lockhart C, Kim SC
Expertise:
,
RWE Research & Consulting
Conference Abstract
Perspectives from a Coordinating Center: Lessons Learned from the Biologics and Biosimilars Collective Intelligence Consortium
Health Care Systems Research Network Conference 2019
April 8, 2019
Authors:
Malek S, King KJ, Lockhart CM, Mendelsohn AB, Brown J
Expertise:
,
RWE Research & Consulting
Conference Abstract
Evaluating Biologics and Their Biosimilars Using a Distributed Research Network to Demonstrate Real-World Outcomes
Academy of Managed Care Pharmacy Nexus 2018
October 26, 2018
Authors:
Pawloski PA, Haynes K, Kent D, McMahill-Walraven CN, Panozzo CA, Pindolia V, Lockhart CM, Brown J, Mendelsohn A, Barr CE, Eichelberger B
